CAPTRUST Financial Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,439
Closed -$354K 2259
2022
Q3
$354K Sell
1,439
-133
-8% -$35.9K ﹤0.01% 1433
2022
Q2
$389K Sell
1,572
-4,188
-73% -$1.13M ﹤0.01% 1270
2022
Q1
$1.91M Buy
5,760
+4,686
+436% +$1.44M 0.01% 608
2021
Q4
$386K Sell
1,074
-119
-10% -$40.2K ﹤0.01% 1253
2021
Q3
$388K Sell
1,193
-154
-11% -$52.2K ﹤0.01% 1154
2021
Q2
$420K Sell
1,347
-277
-17% -$85K ﹤0.01% 1067
2021
Q1
$518K Buy
1,624
+638
+65% +$204K 0.01% 940
2020
Q4
$320K Buy
986
+95
+11% +$26.3K ﹤0.01% 997
2020
Q3
$232K Buy
891
+249
+39% +$71.7K ﹤0.01% 974
2020
Q2
$164K Buy
+642
New +$129K ﹤0.01% 1123
2019
Q4
Sell
-317
Closed -$56K 1939
2019
Q3
$56K Buy
317
+124
+64% +$26.8K ﹤0.01% 961
2019
Q2
$50K Buy
193
+160
+485% +$42.5K ﹤0.01% 970
2019
Q1
$9K Sell
33
-70
-68% -$23.3K ﹤0.01% 1427
2018
Q4
$33K Buy
103
+95
+1,188% +$33K ﹤0.01% 882
2018
Q3
$4K Hold
8
﹤0.01% 1416
2018
Q2
$3K Sell
8
-77
-91% -$27.9K ﹤0.01% 1393
2018
Q1
$24K Buy
+85
New +$21.5K ﹤0.01% 776

Other funds holding ABMD

CAPTRUST Financial Advisors's ABMD Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,439 shares — an estimated $354K sold.

CAPTRUST Financial Advisors first reported a position in ABMD in Q1 2018 and held it in 17 quarters. The position peaked at $1.91M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,439 Abiomed Inc shares in Q4 2022, an estimated $354K.
  • CAPTRUST Financial Advisors first reported a position in Abiomed Inc in Q1 2018 and held it in 17 quarters.
  • CAPTRUST Financial Advisors's Abiomed Inc position peaked at $1.91M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.